Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fabino EnterprisesBOM:543444 68 Quick Ratio is 1.21 as of Mar. 2026, which is 17% below its 10-year median of 1.46. GuruFocus rates BOM:543444 with a GF Score™ of 68/100 and a GF Value™ of ₹37.57. The stock has 5 warning signs investors should review. Among 999 Drug Manufacturers companies, Fabino Enterprises ranks worse than 57.46% on this metric.
Fabino Enterprises has a quick ratio of 1.21. It generally indicates good short-term financial strength.
The historical rank and industry rank for Fabino Enterprises's Quick Ratio or its related term are showing as below:
BOM:543444'
s Quick Ratio Range Over the Past 10 Years
Min: 0.39 Med: 1.46 Max: 8.07
Current: 1.21
During the past 8 years, Fabino Enterprises's highest Quick Ratio was 8.07. The lowest was 0.39. And the median was 1.46.
BOM:543444's Quick Ratio is ranked worse than 57.46% of 999
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs BOM:543444: 1.21
Fabino Enterprises (BOM:543444) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Fabino Enterprises Quick Ratio Related Terms
Fabino Enterprises Quick Ratio Historical Data
* Premium members only.
The historical data trend for Fabino Enterprises's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fabino Enterprises Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Fabino Enterprises's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Fabino Enterprises's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fabino Enterprises (BOM:543444) has a Quick Ratio of 1.21 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Fabino Enterprises and its competitors. This is 17% below median its historical median of 1.46. Over the past decade, Fabino Enterprises' Quick Ratio has ranged from 0.39 to 8.07. According to the industry distribution chart, Fabino Enterprises ranks #574 out of 999 companies in the Drug Manufacturers industry, placing it in the top 57.5%.
Is Fabino Enterprises' Quick Ratio too high?
Fabino Enterprises' current Quick Ratio of 1.21 is 17% below median its 10-year median of 1.46. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 8.07. The Drug Manufacturers industry median Quick Ratio is 1.45. Fabino Enterprises' value of 1.21 is 16.6% below this industry median. Based on the distribution chart, Fabino Enterprises ranks #574 out of 999 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Fabino Enterprises has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Fabino Enterprises' Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Fabino Enterprises ranks #574 out of 999 companies for Quick Ratio. This places Fabino Enterprises in the lower half of its industry. The industry median Quick Ratio is 1.45. Fabino Enterprises' value of 1.21 is 16.6% below this benchmark. Historically, Fabino Enterprises' own Quick Ratio has ranged from 0.39 to 8.07 over the past decade. While the company's 10-year median is 1.46 vs. the industry median of 1.45, Fabino Enterprises has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 999 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fabino Enterprises's current Quick Ratio of 1.21 is 16.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Fabino Enterprises and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fabino Enterprises's current Quick Ratio is 1.21, which is 17% below median its own 10-year median of 1.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fabino Enterprises stock overvalued right now?
Fabino Enterprises (BOM:543444) has a current Quick Ratio of 1.21. The stock's GF Value™ is ₹37.57, compared to a current price of ₹20.31 — trading 45.9% below its estimated fair value. The current Quick Ratio is 1.21, which is 17% below median its 10-year median of 1.46 and 16.6% below the Drug Manufacturers industry median of 1.45. Fabino Enterprises' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Fabino Enterprises (BOM:543444), the current Quick Ratio is 1.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fabino Enterprises (BOM:543444) Overvalued in 2026?
Based on GuruFocus' analysis, Fabino Enterprises stock appears to be undervalued.
The current stock price of ₹20.31 is trading 45.9% below its estimated GF Value™ of ₹37.57.
Key valuation signals for BOM:543444:
Quick Ratio: 1.21 (17% below median its 10-year median of 1.46)
GF Value™: ₹37.57 vs. price of ₹20.31 (45.9% below fair value)
Industry Position: 16.6% below the Drug Manufacturers median (#574 of 999)
No single metric tells the full story. See the BOM:543444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.
68GF Score
Get the complete analysis for BOM:543444
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543444 has been successfully added to your 
